TELL, Gianluca
 Distribuzione geografica
Continente #
NA - Nord America 925
EU - Europa 358
AS - Asia 179
AF - Africa 7
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 3
Totale 1.476
Nazione #
US - Stati Uniti d'America 920
PL - Polonia 96
SE - Svezia 94
CN - Cina 62
UA - Ucraina 39
HK - Hong Kong 35
IT - Italia 35
FI - Finlandia 27
SG - Singapore 26
TR - Turchia 22
DE - Germania 18
KR - Corea 16
IE - Irlanda 12
BG - Bulgaria 11
IN - India 7
SN - Senegal 7
BE - Belgio 6
GB - Regno Unito 6
CA - Canada 4
NL - Olanda 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BR - Brasile 2
DK - Danimarca 2
EE - Estonia 2
EU - Europa 2
IR - Iran 2
JP - Giappone 2
RO - Romania 2
RU - Federazione Russa 2
VN - Vietnam 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
BD - Bangladesh 1
CL - Cile 1
FR - Francia 1
LA - Repubblica Popolare Democratica del Laos 1
MX - Messico 1
PH - Filippine 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 1.476
Città #
Woodbridge 129
Chandler 111
Ann Arbor 108
Fairfield 98
Warsaw 96
Ashburn 91
Houston 54
Seattle 43
Wilmington 42
Jacksonville 39
Cambridge 37
Hong Kong 34
Princeton 22
Beijing 18
Izmir 18
Seoul 16
Dearborn 12
Dublin 12
Singapore 12
Helsinki 11
Sofia 11
Trieste 9
Boardman 8
Dakar 7
San Diego 7
Washington 7
Brussels 6
Hefei 5
Jinan 5
Düsseldorf 4
Falls Church 4
Kocaeli 4
Kunming 4
Mestre 4
Nanchang 4
Toronto 4
Des Moines 3
London 3
Los Angeles 3
Mumbai 3
Shenyang 3
Ardabil 2
Augusta 2
Buffalo 2
Dong Ket 2
Hebei 2
Leawood 2
Nanjing 2
Poggibonsi 2
San Mateo 2
Tallinn 2
Tokyo 2
Udine 2
Amsterdam 1
Berlin 1
Bremen 1
Cattolica 1
Central 1
Chicago 1
Delhi 1
Denver 1
Dhaka 1
Dongguan 1
Dubai 1
Falkenstein 1
Fremont 1
Fuzhou 1
Groningen 1
Guangdong 1
Guangzhou 1
Hanover 1
Jiaxing 1
Manila 1
Mexico City 1
Monmouth Junction 1
Nanning 1
Norwalk 1
Phoenix 1
Rome 1
San Francisco 1
San Jose 1
Shanghai 1
São Paulo 1
Tappahannock 1
Tavagnacco 1
Tianjin 1
Tirana 1
Utrecht 1
Verona 1
Vientiane 1
Yerevan 1
Ürümqi 1
Totale 1.174
Nome #
Serum AP-endonuclease 1 (sAPE1) as novel biomarker for hepatocellular carcinoma 248
APE1/Ref-1 in Alzheimer's disease: An immunohistochemical study 161
Overoxidation of peroxiredoxins as an immediate and sensitive marker of oxidative stress in HepG2 cells and its application to the redox effects induced by ischemia/reperfusion in human liver. 147
Modern strategies to identify new molecular targets for the treatment of liver diseases: The promising role of Proteomics and Redox Proteomics investigations 143
The Many Functions of APE1/Ref-1: Not Only a DNA Repair Enzyme 142
APE1/Ref-1 regulates PTEN expression mediated by EGR-1 126
“Cytosine-block telomeric type DNA-binding activity of hnRNP proteins from human cell lines“ 112
Specific Inhibition of the Redox Activity of Ape1/Ref-1 by E3330 Blocks Tnf-α-Induced Activation of Il-8 Production in Liver Cancer Cell Lines 100
Alterations in the redox state and liver damage: Hints from the EASL Basic School of Hepatology. 100
“The PAX6 gene is activated by the basic helix-loop-helix transcription factor NeuroD/BETA2”. 97
Proteomic analysis of liver tissue subjected to early ischemia/reperfusion injury during human orthotopic liver transplantation 94
Galectin-3 expression in non-small cell lung carcinoma 20
Prognostic role of Ape/Ref-1 subcellular expression in stage I-III breast carcinomas 17
Prognostic significance of Ape1/Ref-1 subcellular localization in non-small cell lung carcinomas 17
Clinical Significance of Apurinic/Apyrimidinic Endodeoxyribonuclease 1 and MicroRNA Axis in Hepatocellular Carcinoma 13
Totale 1.537
Categoria #
all - tutte 4.493
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.493


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020282 18 14 15 39 19 42 43 24 22 15 22 9
2020/2021247 15 8 11 18 28 45 27 11 9 24 21 30
2021/2022162 5 9 4 31 3 19 8 2 20 12 13 36
2022/2023288 30 43 18 48 32 43 1 22 35 1 15 0
2023/2024207 5 9 13 10 35 23 30 38 15 3 18 8
2024/20253 3 0 0 0 0 0 0 0 0 0 0 0
Totale 1.537